Novartis AG (ADR) (NYSE:NVS) announces presentation of data at AAN showing Gilenya (R) slowed the rate of brain volume loss in MS patients . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Novartis AG (ADR) (NYSE:NVS) stock performance was 1.28% in last session and finished the day at $86.45. Traded volume was 2.23million shares … Continue reading Watch List: Novartis AG (ADR) (NYSE:NVS), Stock Building Supply Holdings Inc (NASDAQ:STCK), Acacia Research (NASDAQ:ACTG), Garmin Ltd. (NASDAQ:GRMN)